Overall, hsa-miR-361-3p has been found over-expressed in TNBCs with respect to other subtypes and healthy controls [68]; and used to discriminate BRCA1/2 mutation carriers and non-carriers tumours [69]. The gene discussed is BRCA1; the disease is neoplasm.